The Architecture of Inactivated SARS-CoV-2 with Postfusion Spikes Revealed by Cryo-EM and Cryo-ET
Chuang Liu,Luiza Mendonça,Yang Yang,Yuanzhu Gao,Chenguang Shen,Jiwei Liu,Tao Ni,Bin Ju,Congcong Liu,Xian Tang,Jinli Wei,Xiaomin Ma,Yanan Zhu,Weilong Liu,Shuman Xu,Yingxia Liu,Jing Yuan,Jing Wu,Zheng Liu,Zheng Zhang,Lei Liu,Peiyi Wang,Peijun Zhang
DOI: https://doi.org/10.1016/j.str.2020.10.001
IF: 5.871
2020-11-01
Structure
Abstract:<h2 class="section-title u-h3 u-margin-l-top u-margin-xs-bottom">Summary</h2><p>The ongoing global pandemic of coronavirus disease 2019 (COVID-19) resulted from the outbreak of SARS-CoV-2 in December 2019. Currently, multiple efforts are being made to rapidly develop vaccines and treatments to fight COVID-19. Current vaccine candidates use inactivated SARS-CoV-2 viruses; therefore, it is important to understand the architecture of inactivated SARS-CoV-2. We have genetically and structurally characterized β-propiolactone-inactivated viruses from a propagated and purified clinical strain of SARS-CoV-2. We observed that the virus particles are roughly spherical or moderately pleiomorphic. Although a small fraction of prefusion spikes are found, most spikes appear nail shaped, thus resembling a postfusion state, where the S1 protein of the spike has disassociated from S2. Cryoelectron tomography and subtomogram averaging of these spikes yielded a density map that closely matches the overall structure of the SARS-CoV postfusion spike and its corresponding glycosylation site. Our findings have major implications for SARS-CoV-2 vaccine design, especially those using inactivated viruses.</p>
cell biology,biochemistry & molecular biology,biophysics